Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Lannett Company, Inc. (LCI)

    Price:

    0.69 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    LCI
    Name
    Lannett Company, Inc.
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    0.685
    Market Cap
    7.381M
    Enterprise value
    562.555M
    Currency
    USD
    Ceo
    Timothy C. Crew
    Full Time Employees
    564
    Ipo Date
    2013-12-13
    City
    Trevose
    Address
    1150 Northbrook Drive

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Catalent, Inc.

    VALUE SCORE:

    0

    Symbol
    CTLT
    Market Cap
    11.522B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Bausch Health Companies Inc.

    VALUE SCORE:

    9

    Symbol
    BHC
    Market Cap
    2.238B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Perrigo Company plc

    VALUE SCORE:

    10

    Symbol
    PRGO
    Market Cap
    1.953B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.030
    P/S
    0.022
    P/B
    -0.028
    Debt/Equity
    -2.497
    EV/FCF
    -31.028
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.605
    Earnings yield
    -33.495
    Debt/assets
    1.294
    FUNDAMENTALS
    Net debt/ebidta
    -4.577
    Interest coverage
    -1.211
    Research And Developement To Revenue
    0.066
    Intangile to total assets
    0.066
    Capex to operating cash flow
    -1.472
    Capex to revenue
    0.031
    Capex to depreciation
    0.306
    Return on tangible assets
    -0.512
    Debt to market cap
    84.954
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    -0.000
    P/CF
    -0.971
    P/FCF
    -0.419
    RoA %
    -47.812
    RoIC %
    -18.222
    Gross Profit Margin %
    9.738
    Quick Ratio
    1.858
    Current Ratio
    2.765
    Net Profit Margin %
    -68.008
    Net-Net
    -55.304
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.746
    Revenue per share
    33.762
    Net income per share
    -22.961
    Operating cash flow per share
    -0.706
    Free cash flow per share
    -1.746
    Cash per share
    8.709
    Book value per share
    -24.888
    Tangible book value per share
    -28.078
    Shareholders equity per share
    -24.888
    Interest debt per share
    67.903
    TECHNICAL
    52 weeks high
    3.720
    52 weeks low
    0.011
    Current trading session High
    0.720
    Current trading session Low
    0.650
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.971

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.455

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.014
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.648

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.079

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    -28.923583000000004%
    P/E
    -5.298
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.028

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.723
    DESCRIPTION

    Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

    NEWS
    https://images.financialmodelingprep.com/news/lci-industries-declares-quarterly-cash-dividend-20260227.jpg
    LCI Industries Declares Quarterly Cash Dividend

    businesswire.com

    2026-02-27 08:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.15 per share of common stock. The dividend is payable on March 27, 2026, to stockholders of record at the close of business on March 13, 2026. About LCI Industries LCI Industries (NYSE: LCII), through its Lippert subsidiary, is a global leader in supplyin.

    https://images.financialmodelingprep.com/news/lci-industries-announces-participation-in-upcoming-investor-conferences-20260224.jpg
    LCI Industries Announces Participation in Upcoming Investor Conferences

    businesswire.com

    2026-02-24 16:05:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced its participation in two upcoming investor conferences. On March 2, 2026, President and CEO Jason Lippert and CFO Lillian Etzkorn will participate in the Raymond James 47th Annual Institutional Investors Conference, and on March 3, 2026, CFO Lillian Etzkorn will participate in the JPMorgan Leveraged Finance Conference. At both eve.

    https://images.financialmodelingprep.com/news/lci-industries-thriving-in-a-slow-industry-setting-rating-20260220.jpg
    LCI Industries: Thriving In A Slow Industry Setting (Rating Upgrade)

    seekingalpha.com

    2026-02-20 07:18:29

    LCI Industries: Thriving In A Slow Industry Setting (Rating Upgrade)

    https://images.financialmodelingprep.com/news/lci-industries-reports-fourth-quarter-and-full-year-financial-20260218.jpg
    LCI Industries Reports Fourth Quarter and Full Year Financial Results

    businesswire.com

    2026-02-18 07:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported fourth quarter and full year 2025 results. “We delivered a very strong 2025 with our strategic execution delivering results that validate our multi-year investment in operational excellence and diversification. Despite a difficult wholesale environment in the fourth quarter, our team's relentless focus on innovation, efficiency, an.

    https://images.financialmodelingprep.com/news/lci-industries-announces-upcoming-retirement-of-director-james-gero-20260213.jpg
    LCI Industries Announces Upcoming Retirement of Director James Gero

    businesswire.com

    2026-02-13 08:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, announced the upcoming retirement of James Gero from its Board of Directors, effective at the Company's 2026 Annual Meeting of Stockholders, following 33 years of dedicated service. Mr. Gero served as the Chairman of the Board of LCI Industries from May 2014 to May 2021. Mr. Gero, LCI Industries' longest-serving board member, played a pivotal rol.

    https://images.financialmodelingprep.com/news/lci-industries-fourth-quarter-and-full-year-2025-conference-20260204.jpg
    LCI Industries Fourth Quarter and Full Year 2025 Conference Call Scheduled for February 18, 2026, at 8:30 a.m. ET

    businesswire.com

    2026-02-04 08:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 18, 2026. Conference Call & Webcast LCI Industries will also host a conference call and webcast to discuss its fourth quarter and full year 2025 results on Wednesday, February 18, 2026, at 8:30 a.m. ET. An online, real-time webc.

    https://images.financialmodelingprep.com/news/lci-industries-massive-upside-is-possible-20260119.jpg
    LCI Industries: Massive Upside Is Possible

    seekingalpha.com

    2026-01-19 09:13:23

    LCI Industries: Massive Upside Is Possible

    https://images.financialmodelingprep.com/news/lci-industries-declares-quarterly-cash-dividend-20251113.jpg
    LCI Industries Declares Quarterly Cash Dividend

    businesswire.com

    2025-11-13 16:15:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.15 per share of common stock. The dividend is payable on December 12, 2025, to stockholders of record at the close of business on November 28, 2025. About LCI Industries LCI Industries (NYSE: LCII), through its Lippert subsidiary, is a global leader in su.

    https://images.financialmodelingprep.com/news/lci-industries-to-participate-in-upcoming-truist-conference-20251106.jpg
    LCI Industries to Participate in Upcoming Truist Conference

    businesswire.com

    2025-11-06 07:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, will participate in Truist Securities Gaming, Lodging, Leisure & Restaurants Summit on November 20, 2025. Lillian Etzkorn, Executive Vice President and Chief Financial Officer, will engage in one-on-one meetings with institutional investors and analysts. The conference will be held at the Encore Boston Harbor Hotel, located in Everett, MA. Pl.

    https://images.financialmodelingprep.com/news/world-investment-advisors-takes-position-in-lci-industries-lcii-20251105.png
    World Investment Advisors Takes Position in LCI Industries $LCII

    defenseworld.net

    2025-11-05 03:43:08

    World Investment Advisors purchased a new stake in LCI Industries (NYSE: LCII) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,899 shares of the company's stock, valued at approximately $264,000. Other large investors have also modified their holdings of the company.

    https://images.financialmodelingprep.com/news/critical-survey-evgo-nasdaqevgo-vs-lci-industries-nyselcii-20251105.png
    Critical Survey: EVgo (NASDAQ:EVGO) vs. LCI Industries (NYSE:LCII)

    defenseworld.net

    2025-11-05 01:10:47

    EVgo (NASDAQ: EVGO - Get Free Report) and LCI Industries (NYSE: LCII - Get Free Report) are both auto/tires/trucks companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk. Institutional and Insider Ownership 17.4% of EVgo shares are

    https://images.financialmodelingprep.com/news/lci-industries-reports-third-quarter-financial-results-20251030.png
    LCI Industries Reports Third Quarter Financial Results

    businesswire.com

    2025-10-30 07:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported third quarter 2025 results. “Our diversification strategy has continued to fundamentally contribute to our strong performance, as our team's outstanding efforts resulted in 13% revenue growth, which drove strong margin expansion and a meaningful increase in adjusted earnings per share of 42%. Our leadership teams have worked dilige.

    https://images.financialmodelingprep.com/news/lci-industries-third-quarter-2025-conference-call-scheduled-for-20251014.jpg
    LCI Industries Third Quarter 2025 Conference Call Scheduled for October 30, 2025, at 8:30 a.m. ET

    businesswire.com

    2025-10-14 07:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, will release its third quarter 2025 financial results before the market opens on Thursday, October 30, 2025. Conference Call & Webcast LCI Industries will also host a conference call to discuss its third quarter 2025 results on Thursday, October 30, 2025, at 8:30 a.m. ET. The call will conclude with a question-and-answer session with question.

    https://images.financialmodelingprep.com/news/lci-industries-declares-quarterly-cash-dividend-20250815.jpg
    LCI Industries Declares Quarterly Cash Dividend

    businesswire.com

    2025-08-15 16:15:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.15 per share of common stock. The dividend is payable on September 12, 2025, to stockholders of record at the close of business on August 29, 2025. About LCI Industries LCI Industries (NYSE: LCII), through its Lippert subsidiary, is a global leader in sup.

    https://images.financialmodelingprep.com/news/lci-industries-reports-second-quarter-financial-results-20250805.jpg
    LCI Industries Reports Second Quarter Financial Results

    businesswire.com

    2025-08-05 07:00:00

    ELKHART, Ind,--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported second quarter 2025 results. “We delivered strong second quarter results, led by our innovative portfolio and competitive moat which together fueled share gains across key categories and generated 5% sales growth with 2% organic content growth. Additionally, we tightened our supply chain, cut indirect spend, and further optimized o.

    https://images.financialmodelingprep.com/news/lci-industries-second-quarter-2025-conference-call-scheduled-for-20250722.jpg
    LCI Industries Second Quarter 2025 Conference Call Scheduled for August 5, 2025, at 8:30 a.m. ET

    businesswire.com

    2025-07-22 07:00:00

    ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, will release its second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. Conference Call & Webcast LCI Industries will also host a conference call to discuss its second quarter 2025 results on Tuesday, August 5, 2025, at 8:30 a.m. ET. The call will conclude with a question-and-answer session with questions fr.